Skip to main content
Log in

Maturation and growth of renal function: Dosing renally cleared drugs in children

  • Published:
AAPS PharmSci Aims and scope Submit manuscript

Abstract

A model was developed that characterized the maturation and growth of the renal function parameters (RFPs) glomerular filtration rate (GF), active tubular secretion (AS), and renal plasma flow (QR). Published RFP values were obtained from 63 healthy children between the ages of 2 days and 12 years. Maturation over time was assumed to be exponential from an immature (RFPim) to a mature (RFPma) level; for growth, RFPim and RFPma were assumed to follow the allometric equation: RFP(age, W)=aWbe−kmat *age+cWb(1−e−kmat *age), where W is body weight, kmat is the maturation rate constant, b is the body weight exponent, and a and c are RFPim and RFPma at unit W. The model-based equation was fitted to the age-W, RFP values by a nonlinear least-squares method. For GF, the maturation half-life was 7.9 months (90% maturation, 26 months), the body weight exponent was 0.662, and the ratio c/a (which reflected the magnitude of the maturation influence) was 3.1. For AS and QR, the maturation half-lives were about 3.8 months and the ratio c/a was about 1.8. For renally eliminated drugs, the model can be used to estimate dosing regimens that are based on the adult dosing regimen and the age and weight of the child.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rowland M, Tozer T. Clinical Pharmacokinetics, Concepts and Applications. 3rd ed. Baltimore: Williams and Wilkins, 1995:83–105.

    Google Scholar 

  2. Benet L, Oie S, Schwartz J. Appendix II: Design and optimization of dosage regimens; pharmacokinetic data. In: Hardman J, Limbird L, Molinoff P, Ruddon R, Gilman A, eds. Goodman And Gilmans The Pharmacological Basis Of Therapeutics. 9th ed. New York: McGraw-Hill, 1996:1707–1792.

    Google Scholar 

  3. Crom WR. Pharmacokinetics in the child. Environ Health Perspect. 1994;102:111–117.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Rowland M, Tozer T. Clinical Pharmacokinetics, Concepts and Applications. 3rd ed. Baltimore: Williams and Wilkins, 1995:230–247.

    Google Scholar 

  5. Lam YWF, Banerji S, Hatfield C, Talbert RL. Principles of drug administration in renal insufficiency. Clin Pharmacokinet. 1997;32:30–57.

    Article  CAS  PubMed  Google Scholar 

  6. Hayton W, Kneer J, De Groot R, Stoeckel K. Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants. Antimicrob Agents Chemother. 1996;40:567–574.

    CAS  PubMed Central  PubMed  Google Scholar 

  7. Rubin M, Bruck E, Rapoport M. Maturation of renal function in childhood: clearance studies. J Clin Invest. 1949;28:1144–1162.

    Article  CAS  PubMed Central  Google Scholar 

  8. Schmidt-Nielsen K. Scaling. Why is Animal Size So important? Cambridge: Cambridge University Press; 1984:14–32.

    Book  Google Scholar 

  9. Hallynck T, Soep H, Thomis J, Boelaert J, Daneels R, Dettli L. Should clearance be normalised to body surface or to lean body mass? Br J Pharmacol. 1981;11:523–526.

    Article  CAS  Google Scholar 

  10. Heilbron DC, Holliday MA, Al-Dahwi A, Kogan BA. Expressing glomerular filtration rate in children. Pediatr Nephrol. 1991;5:5–11.

    Article  CAS  PubMed  Google Scholar 

  11. Anderson B, McKee A, Holford N. Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokinet. 1997;33:313–327.

    Article  CAS  PubMed  Google Scholar 

  12. Diem K, Lentner C, eds. Scientific Tables. Basie, Switzerland: Ciba-Geigy Ltd., 1970:693–705.

    Google Scholar 

  13. Kauffman, RE. Status of drug approval processes and regulation of medications for children. Curr Opin Pediatr. 1995;7:195–198.

    Article  CAS  PubMed  Google Scholar 

  14. Anon. Pediatric rule. AAPS News. 1999; February:4–5.

  15. Rowland M, Tozer T. Clinical Pharmacokinetics, Concepts and Applications. 3rd ed. Baltimore: Williams and Wilkins, 1995:254–255.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William L. Hayton.

Additional information

Published: March 3, 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayton, W.L. Maturation and growth of renal function: Dosing renally cleared drugs in children. AAPS PharmSci 2, 3 (2000). https://doi.org/10.1208/ps020103

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/ps020103

KeyWords

Navigation